UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology and treatment of multiple sclerosis in elderly populations

Nature reviews. Neurology, 2019-06, Vol.15 (6), p.329-342

2019

Volltextzugriff (PDF)

Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)

Multiple sclerosis, 2023-05, Vol.29 (6), p.753-756

2023

Volltextzugriff (PDF)

Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium

Journal of neurology, 2024-02, Vol.271 (2), p.711-722

2024

Volltextzugriff (PDF)

Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study

Journal of the neurological sciences, 2023-12, Vol.455, p.122781-122781, Article 122781

2023

Volltextzugriff (PDF)

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium

Multiple sclerosis, 2020-01, Vol.26 (1), p.99-108

2020

Volltextzugriff (PDF)

Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients

Journal of the neurological sciences, 2021-10, Vol.429, p.117618-117618, Article 117618

2021

Volltextzugriff (PDF)

Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis

Journal of the neurological sciences, 2021-01, Vol.420, p.117265-117265, Article 117265

2021

Volltextzugriff (PDF)

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk

Journal of the neurological sciences, 2016-11, Vol.370, p.13-17

2016

Volltextzugriff (PDF)

Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study

Medicina (Kaunas, Lithuania), 2024-07, Vol.60 (7), p.1159

2024

Volltextzugriff (PDF)

Time Interval Providing Highest Yield for Initial EEG in Patients with New Onset Seizures

Epilepsy research, 2016-11, Vol.127, p.229-232

2016

Volltextzugriff (PDF)

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage

Journal of the neurological sciences, 2018-10, Vol.393, p.128-134

2018

Volltextzugriff (PDF)

Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon β-1a users

Neurodegenerative disease management, 2023-06, Vol.13 (3), p.151-159

2023

Volltextzugriff (PDF)

Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset

Multiple sclerosis, 2015-06, Vol.21 (7), p.858-865

2015

Volltextzugriff (PDF)

Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation

Journal of neurology, neurosurgery and psychiatry, 2016-09, Vol.87 (9), p.937-943

2016

Volltextzugriff (PDF)

Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age

Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103406-103406, Article 103406

2022

Volltextzugriff (PDF)

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Vaccines (Basel), 2022-04, Vol.10 (5), p.695

2022

Volltextzugriff (PDF)

Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic

Multiple sclerosis and related disorders, 2022-12, Vol.68, p.104235-104235, Article 104235

2022

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study

JMIR public health and surveillance, 2024-02, Vol.10, p.e45429-e45429

2024

Volltextzugriff (PDF)

A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2022-04, Vol.8 (2), p.20552173221099186-20552173221099186

2022

Volltextzugriff (PDF)

Ketogenic diet: Predictors of seizure control

SAGE open medicine, 2017-01, Vol.5, p.2050312117712887-2050312117712887

2017

Volltextzugriff (PDF)

Disease modifying therapies use associated with comorbid autoimmune diseases in multiple sclerosis patients

Multiple sclerosis and related disorders, 2015-05, Vol.4 (3), p.228-233

2015

Volltextzugriff (PDF)

Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple Sclerosis

International journal of MS care, 2017-11, Vol.19 (6), p.297-302

2017

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis (P12-3.001)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Change in Expanded Timed Get-Up-and-Go is Associated with the Expanded Disability Status Scale and Timed 25-Foot Walk in the New York State Multiple Sclerosis Consortium (4110)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Post-COVID Conditions in People with Multiple Sclerosis: A Cross-sectional Multicenter Study (P1-6.002)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(51)
Buchkapitel
(1)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(19)
Clinical Neurology
(18)
Multiple Sclerosis
(18)
Neurosciences & Neurology
(18)
Female
(10)
Neurosciences
(10)
Adult
(9)
Male
(9)
Retrospective Studies
(8)
Multiple Sclerosis - Epidemiology
(7)
Neurology
(7)
Covid-19
(4)
Middle Aged
(4)
Multiple Sclerosis - Drug Therapy
(4)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(4)
Pandemics
(4)
Patient-Reported Outcomes
(4)
Risk Factors
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology and treatment of multiple sclerosis in elderly populations

Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC)

Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium

Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium

Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients

Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk

Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study

Time Interval Providing Highest Yield for Initial EEG in Patients with New Onset Seizures

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage

Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon β-1a users

Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset

Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation

Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic

Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study

A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis

Ketogenic diet: Predictors of seizure control

Disease modifying therapies use associated with comorbid autoimmune diseases in multiple sclerosis patients

Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple Sclerosis

Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis (P12-3.001)

Change in Expanded Timed Get-Up-and-Go is Associated with the Expanded Disability Status Scale and Timed 25-Foot Walk in the New York State Multiple Sclerosis Consortium (4110)

Post-COVID Conditions in People with Multiple Sclerosis: A Cross-sectional Multicenter Study (P1-6.002)

Suchergebnisse filtern